Effect of itraconazole and rabeprazole on the pharmacokinetics of vimseltinib, an oral inhibitor of the colony-stimulating factor 1 receptor, in healthy participants

Efficacy with vimseltinib in patients with tenosynovial giant cell tumor and prior colony-stimulating factor 1 inhibitor therapy: a phase 2 case series

Effect of a high-fat meal on the pharmacokinetics of vimseltinib, an oral inhibitor of the colony-stimulating factor 1 receptor, in healthy participants

Impact of expert-led education programs on health care provider knowledge of gastrointestinal stromal tumor